Boston Scientific
1,395 hedge funds and large institutions have $111B invested in Boston Scientific in 2024 Q3 according to their latest regulatory filings, with 164 funds opening new positions, 564 increasing their positions, 476 reducing their positions, and 76 closing their positions.
116% more first-time investments, than exits
New positions opened: 164 | Existing positions closed: 76
18% more repeat investments, than reductions
Existing positions increased: 564 | Existing positions reduced: 476
9% more capital invested
Capital invested by funds: $102B → $111B (+$8.86B)
6% more funds holding
Funds holding: 1,317 → 1,395 (+78)
0% more funds holding in top 10
Funds holding in top 10: 36 → 36 (0)
0.38% less ownership
Funds ownership: 90.27% → 89.89% (-0.38%)
30% less call options, than puts
Call options by funds: $661M | Put options by funds: $944M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
A
AustralianSuper
Melbourne,
Australia
|
+$206M |
| 2 |
BlackRock
New York
|
+$180M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$145M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$133M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$120M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$494M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$482M |
| 3 |
Amundi
Paris,
France
|
-$227M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$213M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$203M |
BSX Hedge Fund Activity: Q3 2024 in Review
1,395 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2024, worth a combined $111B — up 8.7% from $102B a quarter earlier.
Buyers outnumbered sellers: 164 funds opened new BSX positions and 76 closed out — a net gain of 88 holders — while 564 added to existing stakes and 476 trimmed.
The largest buyer was AustralianSuper, adding an estimated $206M. The largest seller was Fidelity Investments, cutting an estimated $494M.
- 1,395 institutional investors held Boston Scientific (BSX) as of Q3 2024, up from 1,317 in Q2 2024.
- Funds reported $111B of Boston Scientific stock for Q3 2024, up 8.7% quarter-over-quarter.
- 164 funds opened new Boston Scientific positions in Q3 2024 and 76 closed out, a net change of +88 holders.
- The largest Boston Scientific buyer in Q3 2024 was AustralianSuper, an estimated $206M added.
- The largest Boston Scientific seller in Q3 2024 was Fidelity Investments, an estimated $494M sold.
Based on aggregated 13F filings for Q3 2024.